People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Other Technology, Biotechnology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Anyplace Inc. | — | Other Technology | Series A | $13.1M | $20.6M | 2023 |
| Recida Therapeutics, Inc. | — | Biotechnology | Series A | $5.7M | $204.9M | 2018 |
| Formulate Labs, Inc. | — | Software / Tech | Seed | $2.8M | $4.4M | 2025 |
Michael Savino at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Savino on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Heron | 1 | 11 |
| Jason Calacanis | 1 | 10 |
| David Socks | 1 | 3 |
| Koichi Tanaka | 1 | 2 |
| Yigong Ge | 1 | 2 |
| Osmaan Shah | 1 | 1 |
| Satoru Naito | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.